An automated guideline monitor for secondary prevention of acute myocardial infarction (AMI) has been favorably tested at an academic medical center using a randomized controlled trial. Subsequently, the monitor was implemented in a production mode and has been in production use for five years. Statistical process control analysis shows a generally sustainable effect of the intervention.
|Number of pages||1|
|Journal||AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium|
|State||Published - 2007|